Project measures / variables set:   Xenakis1   latency_Rx

ID, description, units MPD:111156   latency_Rx   latency to move all four paws (extrapyramidal symptoms), treatment group   [s]  
haloperidol study
Measures
• pre-treatment    • post-treatment
Data set, strains Xenakis1   CC RIX   73 strains     sex: both     age: 7-9wks
Procedure inclined screen test
Comparisoncontrol group vs. treated group
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options
Advanced Plot Options
Separate Plot Factor(s)
Legend Factor(s)
X-Axis Factor(s)
Include/Exclude Factor Values

Xenakis1 - latency to move all four paws (extrapyramidal symptoms), treatment group


  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 1 43145.911 43145.911 236.2283 < 0.0001
sex 1 124.5597 124.5597 0.682 0.4096
strain 36 29770.3298 826.9536 4.5277 < 0.0001
group:sex 1 102.2504 102.2504 0.5598 0.455
group:strain 36 21703.1942 602.8665 3.3008 < 0.0001
sex:strain 36 7347.2053 204.089 1.1174 0.3042
group:sex:strain 36 9677.3466 268.8152 1.4718 0.0465
Residuals 275 50227.36 182.6449

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested		SexAge
Xenakis1 111156 inclined screen test haloperidol latency to move all four paws (extrapyramidal symptoms), treatment group   [s]   pre-treatment  latency_Rx_pre CC RIX 72 both 7-9wks
Xenakis1 111157 inclined screen test haloperidol latency to move all four paws (extrapyramidal symptoms), treatment group   [s]   post-treatment  latency_Rx_post CC RIX 70 both 7-9wks



  •   Or, add these measures to your collection.
       
  •     no folder
  •     put them in new folder